CA153 - Overview: Cancer Antigen 15-3 (CA 15-3), Serum
Managing breast cancer patients when used in conjunction with clinical information and other diagnostic procedures Serial testing to assist in early detection of disease recurrence in previously treated stage II and III breast cancer...
FNTSM - Overview: Neurotransmitter Profile 3
Neurotransmitter Profile 3
FMYO3 - Overview: MyoMarker 3 Profile
MyoMarker 3 Profile
HMGCR - Overview: 3-Hydroxy-3-Methylglutaryl Coenzyme-A (HMG-CoA) Reductase, Serum
Evaluating patients with suspected necrotizing autoimmune myopathy Measuring 3-hydroxy-3-methylglutaryl-CoA reductase antibodies
FMMPP - Overview: MyoMarker 3 Plus Profile
MyoMarker 3 Plus Profile
3MGAP - Overview: 3-Methylglutaconic Aciduria Panel, Varies
Follow up for abnormal biochemical results suggestive of 3-methylglutaconic aciduria (3-MGA) Establishing a molecular diagnosis for patients with 3-MGA Identifying variants within genes known to be associated with3-MGA, allowing for...
FFWNC - Overview: Walnut Component rJug r 3
Walnut Component rJug r 3
ZW3 - Overview: Miscellaneous MML Referral Test 3
Miscellaneous MML Referral Test 3
FCCA3 - Overview: Cashew Component rAna o 3
Cashew Component rAna o 3
FPOLO - Overview: Poliovirus (Types 1, 3) Antibodies, Neutralization
Poliovirus (Types 1, 3) Antibodies, Neutralization
LEV3P - Overview: Level 3 Gross and microscopic (Bill Only)
Level 3 Gross and microscopic (Bill Only)
TREE3 - Overview: Tree Panel #3, Serum
Establishing a diagnosis of an allergy to tress in panel #3 Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...
2D66Z - Overview: CYP2D6 3' Gene Duplication/Multiplication (Bill Only)
CYP2D6 3' Gene Duplication/Multiplication (Bill Only)
PR3 - Overview: Proteinase 3 Antibodies, IgG, Serum
Evaluating patients with clinical features of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, specifically granulomatosis with polyangiitis (GPA), microscopic polyangiitis, and eosinophilic granulomatosis with...
APBCS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using serum specimens
APBCC - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Spinal Fluid
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using spinal fluid specimens
Diagnosing growth disorders Diagnosing adult growth hormone deficiency Monitoring of recombinant human growth hormone treatment Insulin-like growth factor binding protein 3 can be used as a possible adjunct to insulin-like growth...
Providing a genetic evaluation for patients with a personal or family history suggestive of atypical hemolytic uremic syndrome (aHUS), thrombotic microangiopathy (TMA), or complement 3 glomerulopathy (C3G) Establishing a diagnosis of...
MPS3B - Overview: Mucopolysaccharidosis III, Three-Enzyme Panel, Blood Spot
Supporting the biochemical diagnosis of mucopolysaccharidoses types IIIA, IIIB, IIIC This test is not useful for carrier detection.
AN3TS - Overview: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Serum
Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for primary lung carcinoma Reporting an end titer result from serum specimens
AN3TC - Overview: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Spinal Fluid
Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for primary lung carcinoma Reporting an end titer result from cerebrospinal fluid specimens
GAL3 - Overview: Galectin-3, Serum
Aiding in the prognosis for patients diagnosed with heart failure Risk stratification of patients with heart failure An early indication of treatment failure and as a therapeutic target
GRAS3 - Overview: Grass Panel # 3, Serum
Establishing a diagnosis of an allergy to cultivated rye, rye, sweet vernal, timothy, and velvet leaf Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...
WEED3 - Overview: Weed Panel # 3, Serum
Establishing a diagnosis of an allergy to English plantain, lamb's quarters, red sorrel, and Russian thistle allergen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic...
3MT - Overview: 3-Methoxytyramine, 24 Hour, Urine
A first- and second-tier screening test for the presumptive diagnosis of catecholamine-secreting pheochromocytomas and paragangliomas Testing in conjunction or as an alternative to plasma metanephrines (PMET / Metanephrines, Fractionated,...
TAU3 - Overview: TAU 3 Immunostain, Technical Component Only
Diagnosis of neurodegenerative disorders
META3 - Overview: Metanephrines with 3-Methoxytyramine, 24 Hour, Urine
A first- and second-tier screening test for the presumptive diagnosis of catecholamine-secreting pheochromocytomas and paragangliomas
UPGC - Overview: Uroporphyrinogen III Synthase (Co-Synthase), Erythrocytes
Diagnosis of congenital erythropoietic porphyria This test is not useful for diagnosis of acute intermittent porphyria (AIP).
GALN3 - Overview: Galectin-3 Immunostain, Technical Component Only
Distinguishing normal and benign thyroid gland from thyroid carcinoma
3FBLN - Overview: Fibulin 3 Immunostain, Technical Component Only
Identification and classification of amyloid types in tissue
MPS3W - Overview: Mucopolysaccharidosis III, Four-Enzyme Panel, Leukocytes
Supporting the biochemical diagnosis of mucopolysaccharidoses types IIIA, IIIB, IIIC, IIID This test is not useful for carrier detection.
GLYP3 - Overview: Glypican-3 Immunostain, Technical Component Only
Differentiating hepatocellular carcinomas from other malignancies and hepatic adenomas
RNAP - Overview: RNA Polymerase III Antibodies, IgG, Serum
Evaluating patients suspected of having systemic sclerosis as part of systemic sclerosis criteria antibody tests Providing diagnostic and prognostic information in patients with systemic sclerosis
PAS3 - Overview: Pediatric Allergy Screen <3 Years, Serum
Establishing a diagnosis of an allergy to egg whites, milk, wheat, soybeans, and house dust mites Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...
PAS38 - Overview: Pediatric Allergy Screen 3 to 8 Years, Serum
Establishing a diagnosis of an allergy to pediatric allergy screen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...
DESG3 - Overview: Desmoglein 3 (DSG3) Immunostain, Technical Component Only
Classification of squamous cell carcinomas
IGFB3 - Overview: Insulin-Like Growth Factor-Binding Protein 3, Serum
Diagnosing growth disorders Diagnosing adult growth hormone deficiency Monitoring of recombinant human growth hormone treatment As a possible adjunct to insulin-like growth factor 1 and growth hormone in the diagnosis and follow-up of...
GATA3 - Overview: GATA Binding Protein 3 Immunostain, Technical Component Only
Characterizing carcinomas, including primary bladder and breast carcinomas, and some types of mesenchymal and neuroectodermal tumors
DSGAB - Overview: Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
Preferred screening test for patients suspected to have an autoimmune blistering disorder of the skin or mucous membranes (pemphigus) Aiding in the diagnosis of pemphigus
LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine
Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.
RPR3 - Overview: Respiratory Profile, Region 3, South Atlantic (GA, N.FA, SC), Serum
Assessing sensitization to various inhalant allergens commonly found in the South Atlantic region, including Georgia, Northern Florida, and South Carolina Defining the allergen responsible for eliciting signs and symptoms Identifying...
APBTS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from serum specimens
Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors
GATAB - Overview: GATA-Binding Protein 3 Immunostain, Technical Component Only, Bone Marrow,
Characterizing carcinomas, including primary bladder and breast carcinomas, and some types of mesenchymal and neuroectodermal tumors
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from spinal fluid specimens
SCARA - Overview: Spinocerebellar Ataxia Type 1, 2, 3, 6, or 7, Repeat Expansion Analysis, Varies
Diagnostic or predictive testing when clinical symptoms or a family history are specific to only one type of spinocerebellar ataxia
C5OHU - Overview: C5-OH Acylcarnitine, Quantitative, Random, Urine
Evaluation of patients with an abnormal newborn screen showing elevations of 3-hydroxyisovaleryl-/2-methyl-3-hydroxybutyryl-carnitine
CASHX - Overview: Cashew Component, IgE, Serum
Evaluation of patients with suspected cashew allergy to component Ana o 3
MPSQU - Overview: Mucopolysaccharides Quantitative, Random, Urine
Supporting the biochemical diagnosis of one of the mucopolysaccharidoses: types I, II, III, IV, VI, or VII
HYOX - Overview: Hyperoxaluria Panel, Random, Urine
Distinguishing between primary and secondary hyperoxaluria Distinguishing between primary hyperoxaluria types 1, 2, and 3
Week in Review: February 3 - Insights
Include: President Biden to End Covid-19 Emergencies On May 11, and Children’s Minnesota Received $3 Million Grant To Address Pediatric Health Disparities....
Leveraging the Laboratory Archives - Page 3 of 3 - Insights
Skip to Content MayoACCESS MayoLINK...
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Phlebotomy Modules: Module 3 | Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: March 3 - Insights
Today's Highlights Include: COVID-19 deaths remain low compared to previous winters, FDA authorizing first at-home combo flu/Covid test, and Rochester public schools evaluating mental health needs and services throughout the district.